A CAR-T trial is one of several efforts that suggest there’s hope of treating the “worst imaginable childhood brain tumor,” ...

Lab-developed tests look likely to be removed from FDA oversight. That has to change, writes Walter G. Johnson.

Researchers, public health and health care groups, advocates, industry, and the public must put tackling diet-related disease ...

RFK Jr.'s 'Make America Healthy Again' agenda focuses on overhauling health care and food to combat chronic disease ...

Good morning health tech readers! Today, details about Amazon’s new mental health partner, another digital health company ...

Facing with a dialogue with RFK Jr., a top FDA official mounts a public defense of vaccines — and pleads for open minds.

Today's health news includes understanding Plan B's efficacy for people with higher BMIs, disparities in infant mortality, ...

In choosing Thune, Republicans went with an establishment candidate with close ties to the outgoing and long-time Senate ...

Measles cases rose 20% worldwide in 2023 compared to the previous year, and vaccination rates still haven't recovered to ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

In a move to safeguard the company’s dominant position in cancer, Merck said Thursday it will license a new cancer drug from ...

For a fifth time this year, the FDA has scolded a pharma company for misleading marketing, this time over a Merz ...